PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
40.25%
Net income growth above 1.5x AVGO's 17.91%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-0.97%
Negative yoy D&A while AVGO is 7.02%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-54.05%
Negative yoy deferred tax while AVGO stands at 100.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-1.28%
Negative yoy SBC while AVGO is 25.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
34.11%
Slight usage while AVGO is negative at -87.50%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-10.74%
Both yoy AR lines negative, with AVGO at -95.79%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-276.47%
Both reduce yoy inventory, with AVGO at -1400.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
49.57%
Lower AP growth vs. AVGO's 133.33%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
99.28%
Growth well above AVGO's 109.26%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
81.82%
Some yoy increase while AVGO is negative at -33.33%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
67.75%
Operating cash flow growth above 1.5x AVGO's 9.61%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-3.90%
Both yoy lines negative, with AVGO at -40.38%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
60.51%
Purchases growth of 60.51% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
64.84%
Liquidation growth of 64.84% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-302.63%
We reduce yoy other investing while AVGO is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
362.95%
We have mild expansions while AVGO is negative at -13.46%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-100.80%
We cut debt repayment yoy while AVGO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-55.83%
Negative yoy issuance while AVGO is 78.95%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-3.19%
We cut yoy buybacks while AVGO is 100.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.